Abstract:Nanoparticles show great potential for drug delivery systems in cancer treatment and diagnosis, which mainly rely on the interaction between nanoparticles and living cells. However, there is still a lack of accurate and large field-of-view imaging techniques to reveal the aggregation and distribution behavior of nanoparticles in whole cancer cells without being destroyed. Here, we demonstrated quantitative imaging of unstained and intact mouse breast cancer cells (4T1) containing 50 nm gold nanoparticles ( NPs) using an X-ray scanning coherent diffraction imaging (ptychography) technique in a large field-of-view. A two-dimensional spatial resolution of 17 nm was achieved on the 4T1 cell. We combine X-ray ptychography and equally sloped tomography (EST) to perform three-dimensional structural mapping, distribution, and aggregation behavior of NPs in cancer cells. By taking full advantage of the large field-of-view, high-resolution, and quantitative imaging technique, the single intracellular NPs are observed and the amount of NPs in aggregations can be accurately quantified. In addition, the morphological changes of lysosomes containing NPs can be observed in the high-contrast mass density images. This study provides an approach for exploring quantitative analysis and physiological delivery of nanomaterials in intact cancer cells at nanoscale resolution, which may greatly benefit the interdisciplinary research of material science, nanomedicine, and nanotoxicology.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c05282?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c05282</a>.TEM images of the morphology of NPs before and after phagocytosis (Figure S1);STXM and ptychography images of 4T1 whole cells with NPs (Figure S2);thickness measurement of the 4T1 cell with an optical microscope (Figure S3);quantitative density analysis of NPs from the ptychography image (Figure S4);A set of projectional images reconstructed from diffraction patterns (Figure S5);A typical PSD curve and 2D projection of a part of the 4T1 cell used for 3D reconstruction (Figure S6);mass density distribution of a slice in the 3D reconstruction of the 4T1 cell with NPs (Figure S7);The amount of NPs contained in all aggregations and their phase shift values in <a class="internalNav" href="#fig4">Figure </a><a class="internalNav" href="#fig4">4</a> (Table S1);The calculation process of the mass density of NPs (Calculation S1); andradiation dose estimation for the 4T1 cell (Calculation S2). (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c05282/suppl_file/ac0c05282_si_001.pdf">PDF</a>)Dynamic display of 3D segmentation structures in the 4T1 cell reconstruction region (Movie S1) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c05282/suppl_file/ac0c05282_si_002.avi">AVI</a>)This article has not yet been cited by other publications.

Revealing the In Situ Behavior of Aggregation-Induced Emission Nanoparticles and Their Biometabolic Effects via Mass Spectrometry Imaging

Revealing the Distribution of Aggregation-Induced Emission Nanoparticles via Dual-Modality Imaging with Fluorescence and Mass Spectrometry

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Dissecting extracellular and intracellular distribution of nanoparticles and their contribution to therapeutic response by monochromatic ratiometric imaging

Complementary imaging of nanoclusters interacting with mitochondria via stimulated emission depletion and scanning transmission electron microscopy

Label-Free Imaging of Nanoparticle Uptake Competition in Single Cells by Hyperspectral Stimulated Raman Scattering.

In situ label-free X-ray imaging for visualizing the localization of nanomedicines and subcellular architecture in intact single cells

Visualizing Dynamics of Sub-Hepatic Distribution of Nanoparticles Using Intravital Multiphoton Fluorescence Microscopy

The Aggregation Induced Emission Probe of Detecting Enhanced Permeation and Retention Effects is Structured for Evaluating the Applicability of Nanotherapy to Different Tumor Individuals.

Laser ablation-single particle-inductively coupled plasma mass spectrometry as a sensitive tool for bioimaging of silver nanoparticles in vivo degradation

Nanoscale Detection of Subcellular Nanoparticles by X-Ray Diffraction Imaging for Precise Quantitative Analysis of Whole Cancer Cells

Early-Stage Imaging of Nanocarrier-Enhanced Chemotherapy Response in Living Subjects by Scalable Photoacoustic Microscopy

In Situ Spatial Analysis of Metabolic Heterogeneity in Single Living Tumor Spheroids Using Nanocapillary-Based Electrospray Ionization Mass Spectroscopy

Label-free Surface-Enhanced Raman Scattering Imaging to Monitor the Metabolism of Antitumor Drug 6-Mercaptopurine in Living Cells.

Microscopic investigation of" topically applied nanoparticles for molecular imaging of fresh tissue surfaces

Nanoaggregate Probe for Breast Cancer Metastasis Through Multispectral Optoacoustic Tomography and Aggregation‐Induced NIR‐I/II Fluorescence Imaging

Ultrastable Near-Infrared Aggregation-Induced Emission Nanoparticles as a Fluorescent Probe: Long-Term Tumor Monitoring and Lipid Droplet Tracking

Enhanced Retention and Cellular Uptake of Nanoparticles in Tumors by Controlling Their Aggregation Behavior.

Nanometer Resolution Mass Spectro-Microtomography for In-Depth Anatomical Profiling of Single Cells

Susceptibility-weighted Imaging for Metabolic Pathway Mapping of Low-Dosage Nanoparticles in Organisms.